Erythropoietin, Gadolinium, and Nephrogenic Fibrosing Dermopathy

  1. Richard N. Hellman, MD
  1. From Indiana University, Indianapolis, Indiana.

TO THE EDITOR:

I read with great interest the article by Swaminathan and colleagues (1) on the possible role of erythropoietin in 22 patients with nephrogenic fibrosing dermopathy. Of interest were the temporal relationship to erythropoietin use, apparent association compared with a control group of higher doses of erythropoietin, and …

This 100-word excerpt has been provided in the absence of an abstract.

| Table of Contents
Most Read Most Read
Most Commented Most Commented On
Annals in the News Annals in the News
Clinical Trials Clinical Trials
Comparative Effectiveness Comparative Effectiveness
Hospital Medicine Hospital Medicine
  • Advertisement
  • Advertisement